87454
document
Resource utilization and costs of care in the diabetes control and complications trial . OBJECTIVE To describe in detail the resources used and costs incurred in the clinical management of patients with insulin-dependent diabetes mellitus ( IDDM ) in the Diabetes Control and Complications Trial ( DCCT ) . RESEARCH DESIGN AND METHODS The resources used for intensive and conventional therapy and to deal with the side effects of therapy were assessed at each of the 29 DCCT clinics and summarized . Unit costs were derived from the DCCT , manufacturers , and Medicare and chosen to reflect what an item would cost to a single-payer national health system . Costs were calculated as the product of resources used and unit costs . The costs of the research component of the DCCT were not included . RESULTS In the DCCT , the annual cost of intensive therapy ( $ 4,000 and $ 5,800/year for multiple daily injections and continuous subcutaneous insulin infusion , respectively ) was approximately three times the cost of conventional therapy ( $ 1,700/year ) . A large portion of the difference in cost was related to the greater frequency of outpatient visits and the greater resources used in self-care . CONCLUSIONS DCCT intensive therapy is more expensive than conventional therapy , but it offers the hope of cost savings as a result of averted complications .
87455
Intervention_Pharmacological
insulin-dependent
87456
Intervention_Physical
intensive and conventional therapy
87457
Outcome_Other
costs of care
87458
Outcome_Other
resources
87459
Outcome_Other
costs incurred
87460
Outcome_Other
Costs
87461
Outcome_Other
costs
87462
Outcome_Other
annual cost of intensive therapy
87463
Outcome_Other
cost of conventional therapy
87464
Outcome_Other
cost
87465
Outcome_Other
frequency of outpatient visits
87466
Outcome_Other
resources used in self-care
87467
Participant_Condition
insulin-dependent diabetes mellitus
87468
Participant_Condition
IDDM
87469
Participant_Sample-size
29